IntelGenx Technologies Corp.
OTC:IGXT
Overview | Financials
Company Name | IntelGenx Technologies Corp. |
Symbol | IGXT |
Currency | USD |
Price | 0.14 |
Market Cap | 24,452,120 |
Dividend Yield | 0% |
52-week-range | 0.09 - 0.27 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. André Godin C.A., CPA, CA, CPA |
Website | https://www.intelgenx.com |
An error occurred while fetching data.
About IntelGenx Technologies Corp.
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD